aluates Reports

$ 0.0

Automative

Global Non-24-hour Sleep-wake Disorder Treatment Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-26E14383

Global Non 24 hour Sleep wake Disorder Treatment Market Research Report 2023

BUY CHAPTERS

Global Non-24-hour Sleep-wake Disorder Treatment Market Research Report 2025

Code: QYRE-Auto-26E14383

Report

May 2025

Pages:77

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Nature's Bounty

Otsuka Pharma (Pharmavite)

Boiron

Miers Laboratories

Genexa

Homeocan inc.

Clinigen Group

Vanda Pharma

Mylan NV

TEVA

Non-24-hour Sleep-wake Disorder Treatment Market Size

The global market for Non-24-hour Sleep-wake Disorder Treatment was valued at US$ 537 million in the year 2024 and is projected to reach a revised size of US$ 808 million by 2031, growing at a CAGR of 6.1% during the forecast period.

Non-24-hour Sleep-wake Disorder Treatment Market

Non-24-hour sleep-wake disorder (N24) is a circadian rhythm sleep disorder in which an individual"s biological clock fails to synchronize to a 24-hour day. Instead of sleeping at roughly the same time every day, someone with N24 will typically find their sleep time gradually delaying by minutes to hours every day.

North American market for Non-24-hour Sleep-wake Disorder Treatment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Non-24-hour Sleep-wake Disorder Treatment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Non-24-hour Sleep-wake Disorder Treatment in Hospital Pharmacies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Non-24-hour Sleep-wake Disorder Treatment include Teva, Mylan, Nature’s Bounty, Otsuka Pharma (Pharmavite), Boiron, Miers Laboratories, Genexa, Homeocan, Clinigen Group, Vanda Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Non-24-hour Sleep-wake Disorder Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-24-hour Sleep-wake Disorder Treatment.

The Non-24-hour Sleep-wake Disorder Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Non-24-hour Sleep-wake Disorder Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Non-24-hour Sleep-wake Disorder Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Non-24-hour Sleep-wake Disorder Treatment Market Report

Report Metric	Details
Report Name	Non-24-hour Sleep-wake Disorder Treatment Market
Accounted market size in year	US$ 537 million
Forecasted market size in 2031	US$ 808 million
CAGR	6.1%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Prescription Drugs OTC
Segment by Application	Hospital Pharmacies Retail Pharmacies Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Teva, Mylan, Nature’s Bounty, Otsuka Pharma (Pharmavite), Boiron, Miers Laboratories, Genexa, Homeocan, Clinigen Group, Vanda Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-24-hour Sleep-wake Disorder Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Non-24-hour Sleep-wake Disorder Treatment Market growing?

Ans: The Non-24-hour Sleep-wake Disorder Treatment Market witnessing a CAGR of 6.1% during the forecast period 2025-2031.

What is the Non-24-hour Sleep-wake Disorder Treatment Market size in 2031?

Ans: The Non-24-hour Sleep-wake Disorder Treatment Market size in 2031 will be US$ 808 million.

Who are the main players in the Non-24-hour Sleep-wake Disorder Treatment Market report?

Ans: The main players in the Non-24-hour Sleep-wake Disorder Treatment Market are Teva, Mylan, Nature’s Bounty, Otsuka Pharma (Pharmavite), Boiron, Miers Laboratories, Genexa, Homeocan, Clinigen Group, Vanda Pharma

What are the Application segmentation covered in the Non-24-hour Sleep-wake Disorder Treatment Market report?

Ans: The Applications covered in the Non-24-hour Sleep-wake Disorder Treatment Market report are Hospital Pharmacies, Retail Pharmacies, Other

What are the Type segmentation covered in the Non-24-hour Sleep-wake Disorder Treatment Market report?

Ans: The Types covered in the Non-24-hour Sleep-wake Disorder Treatment Market report are Prescription Drugs, OTC

Recommended Reports

Sleep Disorder Therapies

Prescription & OTC Sleep

Neurological Treatments

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Prescription Drugs

1.2.3 OTC

1.3 Market by Application

1.3.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Perspective (2020-2031)

2.2 Global Non-24-hour Sleep-wake Disorder Treatment Growth Trends by Region

2.2.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Non-24-hour Sleep-wake Disorder Treatment Historic Market Size by Region (2020-2025)

2.2.3 Non-24-hour Sleep-wake Disorder Treatment Forecasted Market Size by Region (2026-2031)

2.3 Non-24-hour Sleep-wake Disorder Treatment Market Dynamics

2.3.1 Non-24-hour Sleep-wake Disorder Treatment Industry Trends

2.3.2 Non-24-hour Sleep-wake Disorder Treatment Market Drivers

2.3.3 Non-24-hour Sleep-wake Disorder Treatment Market Challenges

2.3.4 Non-24-hour Sleep-wake Disorder Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Non-24-hour Sleep-wake Disorder Treatment Players by Revenue

3.1.1 Global Top Non-24-hour Sleep-wake Disorder Treatment Players by Revenue (2020-2025)

3.1.2 Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Non-24-hour Sleep-wake Disorder Treatment Revenue

3.4 Global Non-24-hour Sleep-wake Disorder Treatment Market Concentration Ratio

3.4.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Non-24-hour Sleep-wake Disorder Treatment Revenue in 2024

3.5 Global Key Players of Non-24-hour Sleep-wake Disorder Treatment Head office and Area Served

3.6 Global Key Players of Non-24-hour Sleep-wake Disorder Treatment, Product and Application

3.7 Global Key Players of Non-24-hour Sleep-wake Disorder Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Non-24-hour Sleep-wake Disorder Treatment Breakdown Data by Type

4.1 Global Non-24-hour Sleep-wake Disorder Treatment Historic Market Size by Type (2020-2025)

4.2 Global Non-24-hour Sleep-wake Disorder Treatment Forecasted Market Size by Type (2026-2031)

5 Non-24-hour Sleep-wake Disorder Treatment Breakdown Data by Application

5.1 Global Non-24-hour Sleep-wake Disorder Treatment Historic Market Size by Application (2020-2025)

5.2 Global Non-24-hour Sleep-wake Disorder Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Non-24-hour Sleep-wake Disorder Treatment Market Size (2020-2031)

6.2 North America Non-24-hour Sleep-wake Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2020-2025)

6.4 North America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size (2020-2031)

7.2 Europe Non-24-hour Sleep-wake Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2020-2025)

7.4 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size (2020-2031)

8.2 Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Non-24-hour Sleep-wake Disorder Treatment Market Size (2020-2031)

9.2 Latin America Non-24-hour Sleep-wake Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2020-2025)

9.4 Latin America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size (2020-2031)

10.2 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Teva

11.1.1 Teva Company Details

11.1.2 Teva Business Overview

11.1.3 Teva Non-24-hour Sleep-wake Disorder Treatment Introduction

11.1.4 Teva Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2020-2025)

11.1.5 Teva Recent Development

11.2 Mylan

11.2.1 Mylan Company Details

11.2.2 Mylan Business Overview

11.2.3 Mylan Non-24-hour Sleep-wake Disorder Treatment Introduction

11.2.4 Mylan Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2020-2025)

11.2.5 Mylan Recent Development

11.3 Nature’s Bounty

11.3.1 Nature’s Bounty Company Details

11.3.2 Nature’s Bounty Business Overview

11.3.3 Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Introduction

11.3.4 Nature’s Bounty Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2020-2025)

11.3.5 Nature’s Bounty Recent Development

11.4 Otsuka Pharma (Pharmavite)

11.4.1 Otsuka Pharma (Pharmavite) Company Details

11.4.2 Otsuka Pharma (Pharmavite) Business Overview

11.4.3 Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Introduction

11.4.4 Otsuka Pharma (Pharmavite) Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2020-2025)

11.4.5 Otsuka Pharma (Pharmavite) Recent Development

11.5 Boiron

11.5.1 Boiron Company Details

11.5.2 Boiron Business Overview

11.5.3 Boiron Non-24-hour Sleep-wake Disorder Treatment Introduction

11.5.4 Boiron Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2020-2025)

11.5.5 Boiron Recent Development

11.6 Miers Laboratories

11.6.1 Miers Laboratories Company Details

11.6.2 Miers Laboratories Business Overview

11.6.3 Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Introduction

11.6.4 Miers Laboratories Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2020-2025)

11.6.5 Miers Laboratories Recent Development

11.7 Genexa

11.7.1 Genexa Company Details

11.7.2 Genexa Business Overview

11.7.3 Genexa Non-24-hour Sleep-wake Disorder Treatment Introduction

11.7.4 Genexa Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2020-2025)

11.7.5 Genexa Recent Development

11.8 Homeocan

11.8.1 Homeocan Company Details

11.8.2 Homeocan Business Overview

11.8.3 Homeocan Non-24-hour Sleep-wake Disorder Treatment Introduction

11.8.4 Homeocan Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2020-2025)

11.8.5 Homeocan Recent Development

11.9 Clinigen Group

11.9.1 Clinigen Group Company Details

11.9.2 Clinigen Group Business Overview

11.9.3 Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Introduction

11.9.4 Clinigen Group Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2020-2025)

11.9.5 Clinigen Group Recent Development

11.10 Vanda Pharma

11.10.1 Vanda Pharma Company Details

11.10.2 Vanda Pharma Business Overview

11.10.3 Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Introduction

11.10.4 Vanda Pharma Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2020-2025)

11.10.5 Vanda Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Nature's Bounty

Otsuka Pharma (Pharmavite)

Boiron

Miers Laboratories

Genexa

Homeocan inc.

Clinigen Group

Vanda Pharma

Mylan NV

TEVA

List of Tables

Table 1. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Prescription Drugs

Table 3. Key Players of OTC

Table 4. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Region (2020-2025)

Table 8. Global Non-24-hour Sleep-wake Disorder Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Region (2026-2031)

Table 10. Non-24-hour Sleep-wake Disorder Treatment Market Trends

Table 11. Non-24-hour Sleep-wake Disorder Treatment Market Drivers

Table 12. Non-24-hour Sleep-wake Disorder Treatment Market Challenges

Table 13. Non-24-hour Sleep-wake Disorder Treatment Market Restraints

Table 14. Global Non-24-hour Sleep-wake Disorder Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Players (2020-2025)

Table 16. Global Top Non-24-hour Sleep-wake Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-24-hour Sleep-wake Disorder Treatment as of 2024)

Table 17. Ranking of Global Top Non-24-hour Sleep-wake Disorder Treatment Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Non-24-hour Sleep-wake Disorder Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Non-24-hour Sleep-wake Disorder Treatment, Headquarters and Area Served

Table 20. Global Key Players of Non-24-hour Sleep-wake Disorder Treatment, Product and Application

Table 21. Global Key Players of Non-24-hour Sleep-wake Disorder Treatment, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Type (2020-2025)

Table 25. Global Non-24-hour Sleep-wake Disorder Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Type (2026-2031)

Table 27. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Application (2020-2025)

Table 29. Global Non-24-hour Sleep-wake Disorder Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Application (2026-2031)

Table 31. North America Non-24-hour Sleep-wake Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Non-24-hour Sleep-wake Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 46. Teva Company Details

Table 47. Teva Business Overview

Table 48. Teva Non-24-hour Sleep-wake Disorder Treatment Product

Table 49. Teva Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2020-2025) & (US$ Million)

Table 50. Teva Recent Development

Table 51. Mylan Company Details

Table 52. Mylan Business Overview

Table 53. Mylan Non-24-hour Sleep-wake Disorder Treatment Product

Table 54. Mylan Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2020-2025) & (US$ Million)

Table 55. Mylan Recent Development

Table 56. Nature’s Bounty Company Details

Table 57. Nature’s Bounty Business Overview

Table 58. Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Product

Table 59. Nature’s Bounty Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2020-2025) & (US$ Million)

Table 60. Nature’s Bounty Recent Development

Table 61. Otsuka Pharma (Pharmavite) Company Details

Table 62. Otsuka Pharma (Pharmavite) Business Overview

Table 63. Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Product

Table 64. Otsuka Pharma (Pharmavite) Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2020-2025) & (US$ Million)

Table 65. Otsuka Pharma (Pharmavite) Recent Development

Table 66. Boiron Company Details

Table 67. Boiron Business Overview

Table 68. Boiron Non-24-hour Sleep-wake Disorder Treatment Product

Table 69. Boiron Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2020-2025) & (US$ Million)

Table 70. Boiron Recent Development

Table 71. Miers Laboratories Company Details

Table 72. Miers Laboratories Business Overview

Table 73. Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Product

Table 74. Miers Laboratories Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2020-2025) & (US$ Million)

Table 75. Miers Laboratories Recent Development

Table 76. Genexa Company Details

Table 77. Genexa Business Overview

Table 78. Genexa Non-24-hour Sleep-wake Disorder Treatment Product

Table 79. Genexa Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2020-2025) & (US$ Million)

Table 80. Genexa Recent Development

Table 81. Homeocan Company Details

Table 82. Homeocan Business Overview

Table 83. Homeocan Non-24-hour Sleep-wake Disorder Treatment Product

Table 84. Homeocan Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2020-2025) & (US$ Million)

Table 85. Homeocan Recent Development

Table 86. Clinigen Group Company Details

Table 87. Clinigen Group Business Overview

Table 88. Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Product

Table 89. Clinigen Group Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2020-2025) & (US$ Million)

Table 90. Clinigen Group Recent Development

Table 91. Vanda Pharma Company Details

Table 92. Vanda Pharma Business Overview

Table 93. Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Product

Table 94. Vanda Pharma Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2020-2025) & (US$ Million)

Table 95. Vanda Pharma Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

Table 99. Authors List of This Report

List of Figures

Figure 1. Non-24-hour Sleep-wake Disorder Treatment Picture

Figure 2. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Type: 2024 VS 2031

Figure 4. Prescription Drugs Features

Figure 5. OTC Features

Figure 6. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Application: 2024 VS 2031

Figure 8. Hospital Pharmacies Case Studies

Figure 9. Retail Pharmacies Case Studies

Figure 10. Other Case Studies

Figure 11. Non-24-hour Sleep-wake Disorder Treatment Report Years Considered

Figure 12. Global Non-24-hour Sleep-wake Disorder Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Non-24-hour Sleep-wake Disorder Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Region: 2024 VS 2031

Figure 15. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Players in 2024

Figure 16. Global Top Non-24-hour Sleep-wake Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-24-hour Sleep-wake Disorder Treatment as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Non-24-hour Sleep-wake Disorder Treatment Revenue in 2024

Figure 18. North America Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Non-24-hour Sleep-wake Disorder Treatment Market Share by Country (2020-2031)

Figure 20. United States Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Non-24-hour Sleep-wake Disorder Treatment Market Share by Country (2020-2031)

Figure 24. Germany Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Market Share by Region (2020-2031)

Figure 32. China Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Non-24-hour Sleep-wake Disorder Treatment Market Share by Country (2020-2031)

Figure 40. Mexico Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Share by Country (2020-2031)

Figure 44. Turkey Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Teva Revenue Growth Rate in Non-24-hour Sleep-wake Disorder Treatment Business (2020-2025)

Figure 48. Mylan Revenue Growth Rate in Non-24-hour Sleep-wake Disorder Treatment Business (2020-2025)

Figure 49. Nature’s Bounty Revenue Growth Rate in Non-24-hour Sleep-wake Disorder Treatment Business (2020-2025)

Figure 50. Otsuka Pharma (Pharmavite) Revenue Growth Rate in Non-24-hour Sleep-wake Disorder Treatment Business (2020-2025)

Figure 51. Boiron Revenue Growth Rate in Non-24-hour Sleep-wake Disorder Treatment Business (2020-2025)

Figure 52. Miers Laboratories Revenue Growth Rate in Non-24-hour Sleep-wake Disorder Treatment Business (2020-2025)

Figure 53. Genexa Revenue Growth Rate in Non-24-hour Sleep-wake Disorder Treatment Business (2020-2025)

Figure 54. Homeocan Revenue Growth Rate in Non-24-hour Sleep-wake Disorder Treatment Business (2020-2025)

Figure 55. Clinigen Group Revenue Growth Rate in Non-24-hour Sleep-wake Disorder Treatment Business (2020-2025)

Figure 56. Vanda Pharma Revenue Growth Rate in Non-24-hour Sleep-wake Disorder Treatment Business (2020-2025)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Sleep Wake Disorder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Circadian Rhythm Sleep Disorders Market Insights Forecast to 2030

Short Sleep Syndrome Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sleep Movement Disorder Drug Market Insights Forecast to 2030

Sleep Disorder Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Insomnia Therapy Market Research Report 2025

Global Desynchronosis Treatment Market Insights Forecast to 2030

Global Jet Lag Therapy Pharmaceuticals Market Insights Forecast to 2030

Global Circadian Rhythm Lighting Market Research Report 2024

Global Sleep Disorders Treatment Services Market Research Report 2025

Global Jet Lag Treatment Market Insights Forecast to 2030

Global Time Zone Change Syndrome Treatment Market Insights Forecast to 2030

Global Insomnia Monitoring Equipment Market Insights Forecast to 2030

Global Non Wearable Sleep Tracker Market Research Report 2024

Global Narcolepsy Treatment Market Research Report 2024

Global Sleep Disorder Therapies Market Research Report 2024

Jet Lag Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Home Sleep Screening Non Wearable Devices Market Insights Forecast to 2030

Circadian Lighting Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Insulin Coolers Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19Z7671

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Ossicular Prostheses Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10V14317

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Defibrillator Accessories Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10O5919

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Septicemia Diagnostic Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4I19963

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions